Last $5.37 USD
Change Today +0.22 / 4.27%
Volume 1.2M
OREX On Other Exchanges
As of 12:21 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Preston S. Klassen M.D., M.H.S.

Head of Global Contrave Program and Senior Vice President of Product Development, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2012


Dr. Preston S. Klassen, M.D., M.H.S., serves as the Head of Global Development and Senior Vice President at Orexigen Therapeutics, Inc. and served as its Senior Vice President of Product Development and Head of Global Contrave Program since November 2009. Dr. Klassen led the global development program for Contrave. Formerly the Therapeutic Area Head for Nephrology and Executive Medical Director at Amgen, Dr. Klassen led global development efforts for its renal franchise. ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

Independent Director


Master's Degree
Duke University
University of Nebraska College of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$610,500

Stock Options*

All Other Compensation$120
Exercisable Options374,873
Unexercisable Options807,127
Total Number of Options1,182,000

Total Compensation*

Total Annual Cash Compensation$610,620
Total Short Term Compensation$610,500
Other Long Term Compensation$120
Total Calculated Compensation$1,266,415
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $5.37 USD +0.22


There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at